AKT1 and neoplasm: Thus, BHLHE40-mediated tumor suppression can be traced to inhibition of oncogenic factors such as STAT1, whereas BHLHE40-mediated promotion of tumor progression may be traced to the activation of the PI3K/Akt/mTOR pathway and the upregulation of pro-survival factors such as survivin and clusterin.